Publication:
The effect of pre-treatment depression, anxiety and somatization levels on transforaminal epidural steroid injection: A prospective observational study

dc.contributor.authorsBahar-Ozdemir Y., Sencan S., Ercalik T., Kokar S., Gunduz O.H.
dc.date.accessioned2022-03-28T15:10:56Z
dc.date.accessioned2026-01-11T16:51:17Z
dc.date.available2022-03-28T15:10:56Z
dc.date.issued2020
dc.description.abstractBackground: Results of the lumbar transforaminal epidural steroid injection (L-TFESI) used in the treatment of lumbar radiculopathy may be affected by the current psychiatric condition of the patient. Objectives: The study aimed to assess the effects of pretreatment comorbid psychiatric conditions on patient outcomes in patients with lumbar disc herniation and radiculopathy. Study Design: The study used a prospective-observational study design. Setting: Research was conducted at a university hospital international pain management center. Methods: In this observational study, 103 patients were included. All patients were evaluated with the Hospital Anxiety and Depression scale (HADS) for depression and anxiety levels and the Somatosensory Amplification Scale (SSAS) for somatization levels before the L-TFESI. The treatment results were evaluated with the Numeric Rating Scale (NRS) and the Oswestry Disability Index (ODI) at baseline, the third week, and the third month. Relative to baseline, a 50% reduction in the NRS was accepted as a successful treatment. Results: HADS-depression, HADS-anxiety, and SSAS levels were similar between the patients with successful treatment outcome and the patients in whom treatment failed. However, there were negative correlations between percent reduction in the NRS and the HADS-depression levels at 3 weeks (r =-0.182, P = .022) and 3 months (r =-0.204, P = .037). Also, there were positive correlations between patients’ pre-injection ODI scores and both the HADS-anxiety (r = 0.271, P = .001) and SSAS (r = 0.201, P = .013) scores. Limitations: The study was limited by a relatively short-term follow-up period. Conclusions: Although psychiatric conditions affected the pain and disability of patients before and after the L-TFESI, and may have an impact on patient-related outcomes, they should not be a reason to not treat patients or expect a lower chance of success. © 2020, American Society of Interventional Pain Physicians. All rights reserved.
dc.identifier.issn15333159
dc.identifier.pubmed32517403
dc.identifier.urihttps://hdl.handle.net/11424/257418
dc.language.isoeng
dc.publisherAmerican Society of Interventional Pain Physicians
dc.relation.ispartofPain Physician
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAnxiety
dc.subjectDepression
dc.subjectDisc herniation
dc.subjectLow-back pain
dc.subjectLumbar radiculopathy
dc.subjectPatientrelated outcomes
dc.subjectSomatization
dc.subjectTransforaminal epidural steroid injection
dc.titleThe effect of pre-treatment depression, anxiety and somatization levels on transforaminal epidural steroid injection: A prospective observational study
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPageE279
oaire.citation.issue3
oaire.citation.startPageE273
oaire.citation.titlePain Physician
oaire.citation.volume23

Files